NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 49 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $30,000 | +233.3% | 56,537 | +334.9% | 0.00% | – |
Q2 2020 | $9,000 | -87.0% | 13,000 | -89.1% | 0.00% | – |
Q1 2020 | $69,000 | -78.9% | 119,181 | -11.0% | 0.00% | – |
Q1 2019 | $327,000 | +890.9% | 133,897 | +493.0% | 0.00% | – |
Q4 2018 | $33,000 | -82.6% | 22,578 | -67.9% | 0.00% | – |
Q3 2018 | $190,000 | -39.1% | 70,444 | -21.3% | 0.00% | – |
Q2 2018 | $312,000 | -18.1% | 89,536 | +18.1% | 0.00% | – |
Q1 2018 | $381,000 | -40.2% | 75,808 | -28.8% | 0.00% | – |
Q4 2017 | $637,000 | – | 106,443 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 4,074,190 | $33,368,000 | 6.74% |
Novo Holdings A/S | 2,903,800 | $23,782,000 | 3.10% |
PURA VIDA INVESTMENTS, LLC | 425,000 | $3,481,000 | 1.02% |
ACUTA CAPITAL PARTNERS, LLC | 400,000 | $3,276,000 | 0.59% |
Monashee Investment Management LLC | 188,000 | $1,540,000 | 0.58% |
Orbimed Advisors | 3,919,600 | $32,102,000 | 0.31% |
FT Options LLC | 20,000 | $164,000 | 0.25% |
Rock Springs Capital Management LP | 625,000 | $5,119,000 | 0.24% |
Rubric Capital Management LP | 300,000 | $2,457,000 | 0.22% |
Ghost Tree Capital, LLC | 120,000 | $983,000 | 0.21% |